Literature DB >> 9201104

Cardiac involvement in progressive muscular dystrophy of the Duchenne type.

K Ishikawa1.   

Abstract

Duchenne's progressive muscular dystrophy (DMD) is a genetic muscle disorder that causes degeneration and atrophy of the systemic and cardiac muscle. The disease is manifested early in childhood, and most of patients die by age 20 years of respiratory failure or heart failure. The cardiac involvement in DMD is characterized pathologically by degeneration and fibrosis of the myocardium, centering around the posterolateral wall of the left ventricle. Functionally, an abnormal electrocardiogram, valve motion, wall thickness, and wall motion are observed. Furthermore, abnormalities in plasma levels of atrial natriuretic peptide and autonomic function are also demonstrated. In this review, the cardiac involvements in DMD in the following aspects are described: 1) Electrocardiogram; a) high-frequency notches on the QRS complexes, b) amplitude of QRS complexes, c) late potential, d) arrhythmias, e) heart rate variability, f) a 10-year follow-up study, 2) Echocardiographic findings, 3) Hemodynamic findings, 4) Atrial natriuretic peptide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201104     DOI: 10.1536/ihj.38.163

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  6 in total

1.  Patchy or homogenous myocardial fibrosis in Becker muscular dystrophy? Comments on Süselbeck et al., Z Kardiol 94:465-468/2005.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2006-04       Impact factor: 5.460

2.  Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.

Authors:  J Rhodes; R Margossian; B T Darras; S D Colan; K J Jenkins; T Geva; A J Powell
Journal:  Pediatr Cardiol       Date:  2007-09-21       Impact factor: 1.655

Review 3.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

4.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.

Authors:  Dewayne Townsend; Immanuel Turner; Soichiro Yasuda; Joshua Martindale; Jennifer Davis; Michael Shillingford; Joe N Kornegay; Joseph M Metzger
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

Review 5.  Cardiopulmonary support in duchenne muscular dystrophy.

Authors:  Josef Finsterer
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

Review 6.  Electrocardiographic features of children with Duchenne muscular dystrophy.

Authors:  Liting Tang; Shuran Shao; Chuan Wang
Journal:  Orphanet J Rare Dis       Date:  2022-08-20       Impact factor: 4.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.